Year: 2001
Type: editorial
Abstract: Assessing allocation concealment and blinding in randomised controlled trials: why bother?The EBN users' guide in the previous issue of Evidence-Based Nursing outlined the primary and secondary questions for evaluating studies of healthcare interventions.One of the primary questions for assessing the validity of a study's findings is whether the assignment of patients to treatments was randomised and whether randomisation was concealed.One of the secondary questions is whether patients, clinicians, outcome assessors, and data analysts were unaware of (blinded to or masked from) patient allocation.Beginning with the October 1999 issue of Evidence-Based Nursing, allocation concealment and blinding have been given more attention.The "design" section of abstracts of randomised trials now includes a statement of whether randomisation was concealed from those responsible for entering patients into trials, and who was blinded to treatment allocation during the trials.These additional specifications provide readers with more information to judge the internal validity of trials.In this editorial, the background and rationale for these decisions are addressed.
Source: Evidence-Based Nursing
DOI: 10.1136/ebn.4.1.4
Author: Kenneth F Schulz
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Statistics, Probability and Uncertainty
Field: Decision Sciences
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W2170567254
